Сочетание гамартомы и метастаза рака щитовидной железы в одной доле легкого

Гамартома , легкое , метастаз , щитовидная железа

1. Вишневский А.А., Кармазановский Г.Г., Коков Л.С. и др. Современные возможности диагностики в торакальной хирургии. Хирургия 2003; 3: 92-95.

2. Вишневский А.А., Пикунов М.Ю., Кармазановский Г.Г. и др. Вопросы диагностики малых очаговых периферических образований легких. Альманах Института хирургии им. А.В.Вишневского 2007; 2: 19-37.

3. Travis W.D., Brambilla E., Muller-Hermelink H.K., Harris C.C. Pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARCPress; 2004. 113-114.

4. Bosch J.M., Wagenaar S.S., Corrin B. et al. Mesenchymoma of the lung (so called hamartoma): a review of 154 parenchymal and endobronchial cases. Thorax 1987; 42: 790-793.

5. Higashita R., Ichikawa S., Ban T. et al. Coexistence of lung cancer and hamartoma. J. Thorac. Cardiovasc. Surg. 2001; 49: 258-260.

6. Hess J.L. Chromosomal translocations in benign tumors: the HMGI proteins. Am. J. Clin. Pathol. 1998; 109: 251-261.

7. Kaye F.J. RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer. Oncogene 2002; 21: 6908-6914.

8. Ribet M., Jaillard-Thery S., Nuttens M.C. Pulmonary hamartoma and malignancy. J. Thorac. Cardiovasc. Surg. 1994; 107: 611-614.

9. Poulsen J.T., Jacobsen M., Francis D. Probable malignant transformation of pulmonary hamartoma. Thorax 1979; 34: 557-558.

10. Zetter B.R. The cellular basis of site-specific tumor metastasis. N. Engl. J. Med. 1990; 322: 605-612.

11. Flint A., Lloyd RV. Pulmonary metastases of colonic carcinoma. Distinction from pulmonary adenocarcinoma. Arch. Pathol. Lab. Med. 1992; 116: 39-42.

12. Pipitone S., Mongiovi M., Grillo R. et al. Cardiac rhabdomyoma in intrauterine life: clinical features and natural history. A case series and review of published reports. Ital. Heart J. 2002; 3: 48-52.

13. Whitesell P.L., Peters S.G. Pulmonary manifestations of extrathoracic malignant lesions. Mayo Clin. Proc. 1993; 68: 483-491.

14. Silverberg S.G., DeLellis R.A., Frable W.J. et al., eds. Principles and practice of surgical pathology and cytopathology. 4th ed. Philadelphia: Elsevier Inc.; 2006.

15. Rosai J. Rosai and Askerman's surgical pathology. 9th ed. Missouri: Mosby; 2004.

16. Ng W.K., Chow J.C., Ng P.K. Thyroid transcription factor-1 is highly sensitive and specific in differentiating metastatic pulmonary from extrapulmonary adenocarcinoma in effusion fluid cytology specimens. Cancer 2002; 96: 43-48.

17. Dabbs D.J. Diagnostic immunohistochemistry. 2nd ed. Philadelphia: Elsevier Inc., 2006.

18. Werling R.W., Yazjii H., Bacchi C., Gown A.M. CDX2, a highly sensitive and specific marcer of adenocarcinomas of intestinal origin. Am. J. Surg. Pathol. 2003; 27: 303-310.

19. Петров С.В. Иммуногистохимическая диагностика опухолей легкого, мезотелиомы. В кн.: Петрова С.В., Райхлина Н.Т. (ред.). Руководство по иммуногистохимической диагностике опухолей человека. Казань: Титул; 2004. 55-60.

20. Umemori Y., Ando A., Okabe K. et al. Clinical analysis of lang cancer in patients with chondromatous hamartoma. Kyobu Geka 1995; 48: 1061-1064.

21. Tojo Y., Bandoh S., Fujita J. et al. A case of synchronous primary lung cancer with hamartoma. Nihon Kokyuki Gakkai Zasshi 2003; 41: 474-479.

22. Abe Y., Shioya S., Ohshika Y. et al. Clinicopathological study of pulmonary hamartoma with special reference to 6 patients who also had another tumor. Nihon Kokyuki Gakkai Zasshi 1996; 34: 1354-1358.

23. King T.C., Myers J. Isolated metastasis to a pulmonary hamartoma. Am. J. Surg. Pathol. 1996; 20: 384.